Acetylsalicylic acid Completed Phase 4 Trials for Cerebral Infarctions / Stroke Prevention

IndicationsStatusPurposePhase
CompletedPrevention4
clinicaltrials.gov IdentifierTitleDrugs
NCT00004727Antiplatelet Therapy to Prevent Stroke in African Americans
NCT00234065Post-marketing Study of Cilostazol (Cilostazol Stroke Prevention Study 2)
NCT00153062PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes